About Our Facilities
ACTRIS is located within the National Cancer Centre Singapore (NCCS), which houses the state-of-the-art facility. Within this facility are current Good Manufacturing Practice (cGMP) suites dedicated to meeting the growing demand for process development and manufacturing of cell, tissue, and gene therapy (CTGT) products, alongside related translational research in Singapore and across the broader ASEAN region.
ACTRIS has obtained Good Manufacturing Practices (GMP) certification and Manufacturer’s License (ML) from Health Sciences Authority (HSA), ensuring quality compliance in cellular therapy manufacturing and clinical services.
The facility also continues to incorporate advanced technologies to support the manufacturing of CTGT products, serving both the public and private sectors in Singapore.